688247 宣泰医药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.8995.1169.87321.28724.971
总资产报酬率 ROA (%)1.6874.5348.45616.81619.720
投入资产回报率 ROIC (%)1.8194.8909.30919.00522.599

边际利润分析
销售毛利率 (%)45.45155.89371.22978.12781.522
营业利润率 (%)23.86523.01440.04338.45544.618
息税前利润/营业总收入 (%)22.54619.59235.94248.12948.017
净利润/营业总收入 (%)20.55120.36737.53942.76738.632

收益指标分析
经营活动净收益/利润总额(%)97.92381.64765.80162.76780.579
价值变动净收益/利润总额(%)3.81317.22822.3443.11117.512
营业外收支净额/利润总额(%)-0.698-4.578-1.69918.589-0.059

偿债能力分析
流动比率 (X)9.93710.49410.5916.9133.831
速动比率 (X)9.0879.56210.2646.4613.537
资产负债率 (%)11.26711.11611.63818.55123.880
带息债务/全部投入资本 (%)-0.115-0.826-0.377-2.2809.773
股东权益/带息债务 (%)-83,335.791-11,620.942-25,208.639-4,074.718870.765
股东权益/负债合计 (%)787.583799.583759.286439.047318.762
利息保障倍数 (X)-19.543-8.114-10.47253.84414.018

营运能力分析
应收账款周转天数 (天)56.31278.16776.12038.11332.022
存货周转天数 (天)122.588155.124176.402214.523163.728